Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 19 - Sep 24
stdei glp-1 Wegovy Supply Options:3 Month Supply TP-Active New Phase 3 retatrutide
New Phase 3 retatrutide data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats
10.1111/acer.13199 [DOI] [PMC free article] [PubMed] [Google Scholar] Sørensen G., Reddy I
TP-Active
Supply Options:3 Month Supply
Beyond the chart: Use this chart: Marketers can use this chart to align health messaging with surging demand for weight-loss treatments, and consider the value of TV ads even as the broader industry shifts digital
US$ 28.33
US$ 22.76
US$ 21.28
US$ 21.87
US$ 29.65
US$ 24.94
US$ 23.32
